Dr. Reddy's Laboratories (English Wikipedia)

"Dr Reddy's API plant receives USFDA 483 with nine observations". in-pharmatechnologist.com. 27 November 2014. Archived from the original on 9 July 2015. Retrieved 21 September 2015.

indiatimes.com

economictimes.indiatimes.com

Dec 22, PTILast Updated (22 December 2022). "Indian pharma sector set for 'volume to value leadership' journey in 2023". The Economic Times. ISSN 0013-0389. Archived from the original on 5 August 2023. Retrieved 6 August 2023.{{cite news}}: CS1 maint: numeric names: authors list (link)
Pilla, Viswanath (22 March 2024). "Dr Reddy's enters licensing pact to market Pharmazz novel therapy Centhaquine in India". The Economic Times.

health.economictimes.indiatimes.com

www.ETHealthworld.com. "Dr. Reddy's launches patient-centric Purple Health initiative - ET HealthWorld". ETHealthworld.com.

timesofindia.indiatimes.com

"Dr Reddy's launches 'patient-friendly' packaging on certain medicines - Times of India". The Times of India. September 2016.

ipa-india.org

"Introducing IPA- Indian Pharmaceutical Alliance". IPA, Indian Pharmaceutical Alliance. Archived from the original on 9 April 2024. Retrieved 6 August 2023.

leave-russia.org

"Dr. Reddy's Laboratories". leave-russia.org. Archived from the original on 7 January 2025. Retrieved 7 January 2025.

livemint.com

Pilla, Viswanath (28 March 2016). "Dr Reddy's enters into licensing pact with US-based XenoPort". livemint.com. Archived from the original on 10 April 2016. Retrieved 29 March 2016.
Perlecan highlights R&D travails of Indian pharma , 17 October 2008.Accessed: 18 October 2009.
DRL moving research arm to Bangalore unit 22 May 2009. Accessed: 20 August 2009.

marketreports.com

Dr Reddy's Laboratories 2007-2012 – MarketReports.com 2007 life sciences research report, Technology Networks, Sudbury, Essex, UK Archived 19 January 2010 at the Wayback Machine.Accessed: 22 August 2007.

ndtv.com

profit.ndtv.com

Pfizer in talks to buy DRL’s formulations business in India, NDTV, New Delhi, 23 February 2010 Archived 14 July 2011 at the Wayback Machine.Accessed 2 October 2010.

nytimes.com

Thomas, Katie (23 June 2014). "Warning Unheeded, Heart Drugs are Recalled". The New York Times. Archived from the original on 24 June 2014. Retrieved 2 December 2022.

pravda.ru

english.pravda.ru

Dr. Reddy's Laboratories will no longer produce its medicines in Russia – Pravda.ru 8 February 2005.Accessed: 28 November 2011.

reuters.com

Dr. Reddy's Laboratories Limited Says Not To Sell Any Business-DJ, Reuters news agency, 23 March 2010^{[dead link]}.Accessed 2 October 2010.
Ahmed, Aftab; Kumar, Anuron Mitra (11 January 2021). "Russia's Sputnik V vaccine found safe in India mid-stage trial - Dr.Reddy's". Reuters. Archived from the original on 5 February 2021. Retrieved 26 January 2021.
Das, Nigam Prusty, Krishna N. (12 April 2021). "Indian panel gives emergency approval for Russia's Sputnik V vaccine". Reuters. Archived from the original on 12 April 2021. Retrieved 14 April 2021.{{cite news}}: CS1 maint: multiple names: authors list (link)
"India says its safety study of Sputnik V vaccine comparable to Russian trial". Reuters. 13 April 2021. Archived from the original on 13 April 2021. Retrieved 14 April 2021.

in.reuters.com

"Dr Reddy's to buy some UCB brands for $128 million". reuters.com. 20 May 2023. Archived from the original on 6 March 2016.

stockwatch.in

Pfizer Sues Dr Reddy’s Over Cholesterol Drug ‘Lipitor’ , Stock Watch, Mumbai, 12 November 2009 Archived 20 May 2011 at the Wayback Machine.Accessed 2 October 2010.

thehindu.com

"Dr. Reddy's to market U.S. firm Pharmazz's hypovolemic shock drug in India". The Hindu. 22 March 2024. Archived from the original on 29 May 2024. Retrieved 29 May 2024.
"Russia inks pact to test, supply Sputnik V vaccine to India". The Hindu. 16 September 2020. Archived from the original on 21 October 2021. Retrieved 16 September 2020.
Staff Reporter (24 November 2014). "Villagers seek closure of drug unit in Peddadevulapally". The Hindu. ISSN 0971-751X. Retrieved 27 March 2021.

thehindubusinessline.com

"Beyond the pill: Dr Reddy's rolls out patient-centric Purple Health initiative". thehindubusinessline.com. September 2016.

web.archive.org

"Archived copy" (PDF). Archived from the original (PDF) on 25 May 2014. Retrieved 24 May 2014.{{cite web}}: CS1 maint: archived copy as title (link)
Dr Reddy's Laboratories 2007-2012 – MarketReports.com 2007 life sciences research report, Technology Networks, Sudbury, Essex, UK Archived 19 January 2010 at the Wayback Machine.Accessed: 22 August 2007.
Dec 22, PTILast Updated (22 December 2022). "Indian pharma sector set for 'volume to value leadership' journey in 2023". The Economic Times. ISSN 0013-0389. Archived from the original on 5 August 2023. Retrieved 6 August 2023.{{cite news}}: CS1 maint: numeric names: authors list (link)
"Introducing IPA- Indian Pharmaceutical Alliance". IPA, Indian Pharmaceutical Alliance. Archived from the original on 9 April 2024. Retrieved 6 August 2023.
"Dr Reddy's to buy some UCB brands for $128 million". reuters.com. 20 May 2023. Archived from the original on 6 March 2016.
Pilla, Viswanath (28 March 2016). "Dr Reddy's enters into licensing pact with US-based XenoPort". livemint.com. Archived from the original on 10 April 2016. Retrieved 29 March 2016.
"Dr. Reddy's to market U.S. firm Pharmazz's hypovolemic shock drug in India". The Hindu. 22 March 2024. Archived from the original on 29 May 2024. Retrieved 29 May 2024.
Dr. Reddy’s receives exclusive rights for Zocor Archived 22 February 2006 at the Wayback Machine
Pfizer in talks to buy DRL’s formulations business in India, NDTV, New Delhi, 23 February 2010 Archived 14 July 2011 at the Wayback Machine.Accessed 2 October 2010.
Dr Reddy's develops generic version of Pfizer's Lipitor, Business Standard, New Delhi and Mumbai, 7 November 2009 Archived 8 November 2009 at the Wayback Machine.Accessed 2 October 2010.
Pfizer Sues Dr Reddy’s Over Cholesterol Drug ‘Lipitor’ , Stock Watch, Mumbai, 12 November 2009 Archived 20 May 2011 at the Wayback Machine.Accessed 2 October 2010.
AstraZeneca Partners with India's Torrent Pharmaceuticals, Pharmaceutical Technology, Iselin, NJ and Chester UK Archived 11 July 2011 at the Wayback Machine.Accessed 2 October 2010.
"Russia's sovereign wealth fund partners with Dr Reddy's for trials and distribution of Sputnik V vaccine in India". Hindustan Times. 16 September 2020. Archived from the original on 30 April 2021. Retrieved 16 September 2020.
"Russia inks pact to test, supply Sputnik V vaccine to India". The Hindu. 16 September 2020. Archived from the original on 21 October 2021. Retrieved 16 September 2020.
Ahmed, Aftab; Kumar, Anuron Mitra (11 January 2021). "Russia's Sputnik V vaccine found safe in India mid-stage trial - Dr.Reddy's". Reuters. Archived from the original on 5 February 2021. Retrieved 26 January 2021.
Das, Nigam Prusty, Krishna N. (12 April 2021). "Indian panel gives emergency approval for Russia's Sputnik V vaccine". Reuters. Archived from the original on 12 April 2021. Retrieved 14 April 2021.{{cite news}}: CS1 maint: multiple names: authors list (link)
"India says its safety study of Sputnik V vaccine comparable to Russian trial". Reuters. 13 April 2021. Archived from the original on 13 April 2021. Retrieved 14 April 2021.
Thomas, Katie (23 June 2014). "Warning Unheeded, Heart Drugs are Recalled". The New York Times. Archived from the original on 24 June 2014. Retrieved 2 December 2022.
"Dr Reddy's API plant receives USFDA 483 with nine observations". in-pharmatechnologist.com. 27 November 2014. Archived from the original on 9 July 2015. Retrieved 21 September 2015.
Dr. Reddy's confirms its voluntary nationwide recall of all Ranitidine products in the U.S. Market 23 October 2019 Archived 24 October 2019 at the Wayback Machine. Accessed: 24 October 2019.
"FDA Requests Removal of All Ranitidine Products (Zantac) from the Market". FDA. 2 April 2020. Archived from the original on 28 March 2021. Retrieved 11 September 2023.
"Class 2 Medicines Recall: Aripiprazole 1mg/ml oral solution EL (19)A/21.". Archived from the original on 28 November 2021. Retrieved 28 November 2021.
"Dr. Reddy's Laboratories". leave-russia.org. Archived from the original on 7 January 2025. Retrieved 7 January 2025.
"Over 1,000 Companies Have Curtailed Operations in Russia—But Some Remain | Yale School of Management". som.yale.edu. Archived from the original on 16 June 2022. Retrieved 7 January 2025.
Dunleavy, Kevin (19 May 2022). "Dr. Reddy's to launch new brands in Russia". www.fiercepharma.com. Archived from the original on 7 January 2025. Retrieved 7 January 2025.

worldcat.org

search.worldcat.org

Dec 22, PTILast Updated (22 December 2022). "Indian pharma sector set for 'volume to value leadership' journey in 2023". The Economic Times. ISSN 0013-0389. Archived from the original on 5 August 2023. Retrieved 6 August 2023.{{cite news}}: CS1 maint: numeric names: authors list (link)
Staff Reporter (24 November 2014). "Villagers seek closure of drug unit in Peddadevulapally". The Hindu. ISSN 0971-751X. Retrieved 27 March 2021.

yale.edu

som.yale.edu

"Over 1,000 Companies Have Curtailed Operations in Russia—But Some Remain | Yale School of Management". som.yale.edu. Archived from the original on 16 June 2022. Retrieved 7 January 2025.